What You Should Know:
- Biotech company Phenomix Sciences launches its biobanking registry, marking the first obesity registry to study the impact of personalized treatment based on phenotyping. The impact of this biobanking registry and the data it will yield has the potential to change the entire system’s approach to obesity, from a treatment recommendation to the way payers determine coverage and how the industry combines diagnostics testing with drug therapy.
- The
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Genetics Startup Pleno Launches Out of Stealth with $15M
What You Should Know:
- Pleno, a multi-omics startup, is emerging out of stealth with a $15M Pre-Series A financing and Greg Lucier as Chairman of the Board of Directors. Founded by Pieter van Rooyen, a well-known biotech engineer who built and sold his last company, Edico Genome, to Illumina for $100M. Edico's Dragen technology has become a staple in genetics research.
- Pleno's Hypercoding technology has the potential to revolutionize biological target detection for
Read More
Reproducibility, Trust, and the Digital Laboratory
Over the last decade, there has been an increasing recognition that results published in scientific journals often cannot be reproduced by other scientists. This has been called the “reproducibility crisis” and has been described in a number of studies. A 2016 Nature article reported that more than 70% of surveyed researchers tried and failed to reproduce another scientist's experiments, and more than half have failed to reproduce their own experiments. A 2021 study reported that fewer than half
Read More
Tempus Launches Psychiatric Real-World Data Collaboration
What You Should Know:
- Tempus, an $8B precision medicine company, announced the launch of a new psychiatric real-world data program to leverage real-world data to inform mental health treatment.
- Tempus N+ is a collaboration between provider institutions across the country and Tempus to build an infrastructure for data-driven research – providers can seamlessly and securely contribute molecular and clinical data, and in turn, their clinicians and researchers can access a
Read More
Cerner Collaboration to Increase Access to Cancer Clinical Trials
What You Should Know:
- Cerner, Elligo Health Research® and Freenome are collaborating to enable a clinical trial through the Learning Health Network to help advance early cancer detection.
- Together they will be using the research-activated network of health systems, real-world data (RWD) and multiomics technology, developed by Freenome, with the goal to help accelerate early cancer detection.
Importance of Early Cancer Detection
Early
Read More
Eli Lilly Partners with Yseop to Expedite Drug Approval Process
What You Should Know:
- Eli Lilly and Company partners with Yseop, an AI software company and pioneer in Natural Language Processing (NLP) to deploy Yseop’s world-class enterprise automation platform, Augmented Analyst, to accelerate bringing Lilly’s medicines to patients.
- Yseop’s platform uses Natural Language Generation (NLG) to augment human analysis with automated insights. With Yseop’s powerful AI automation technology, teams can shorten the time spent on specialist medical reports
Read More
Arcadia & Datavant Partner to Accelerate Whole-Person Care & Biopharma Research
What You Should Know:
- Arcadia and Datavant today announced a partnership to enable de-identified connectivity of Arcadia’s electronic health record data for life sciences research and commercial analytics.
- This partnership will unlock fresh insights to accelerate whole-person care and biopharma research, extending Arcadia’s leadership in empowering a data-driven transformation of healthcare.
- Datavant will allow clients to connect Arcadia data to other types of Real World Data
Read More
How the Life Sciences Industry Can Boost Diversity and Inclusion Efforts
Although it is well established that diversity improves outcomes and drives excellence, implementing diversity lags behind in many industries, including life sciences and healthcare.
Diversity is lacking across the entire field, from academic research to clinical work, composition of the workforce, and medical practice. This leads to worse health outcomes and fewer professional opportunities for underserved demographics, such as racial and ethnic minorities, women, and people with
Read More
Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic Medicines
What You Should Know:
- Kelonia Therapeutics, a Boston-based biotech company focused on vivo gene delivery, launched with a $50 million in Series A funding to expand the benefit and reach of genetic medicines.
- Despite life-changing responses, existing gene therapies are highly complex, costly, and limited by complicated treatment paradigms, tractable therapeutic applications, and dose-limiting toxicities. By enabling precisely targeted, highly efficient, manufacturable “off-the-shelf” in
Read More
3 Keys to Eliminating Data Breakdowns in Life Sciences
Across life sciences, experts boldly predict that data is the new currency—and that mobilizing data from clinical trials, wearable devices and even social media will ignite innovation in 2022. But leveraging data for innovation depends not just on data analytics, but also access to the right data and timely analysis.
As the amount of data that life sciences experts have at their fingertips explodes, with leaders tapping into real-world evidence from smartphone apps, wearable devices and
Read More
